Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,451.60
(
-1.13%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
2.39%
)
Bitcoin
70,808.01
(
1.30%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: buddiet post# 2910

Monday, 03/05/2007 11:59:06 AM

Monday, March 05, 2007 11:59:06 AM

Post# of 19309
The subject of follow-on biologics has been extensively discussed on iHub’s Biotech Values board for the past few years. Here are some references:

#msg-17057467 (Latest legislation)
#msg-13425482 (Overview of the issues)
#msg-11358021 (FDA approval of Omnitrope)
#msg-5251149 (This 2004 article is still a good read)

Regards, Dew

p.s. Welcome to the board!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today